Here below are the publications (4) participated by Carlo Catapano along with Aleksandra Kokanovic (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate Cancer
European Urology Oncology, giugno 2021

2) Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease
Nature Communications, 26 dicembre 2022

3) EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Nature Communications, 6 luglio 2021

4) Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
Communications Biology, 26 gennaio 2021
Carlo Catapano
is currently collaborating with
Istituto Oncologico di Ricerca (IOR) (Rif. IOR)
Via Francesco Chiesa 5
6500 Bellinzona
Carlo Catapano
on behalf of
Istituto Oncologico di Ricerca (IOR) USI (Rif. IOR)
is currently participating in the Research Group
Experimental Therapeutics
as Group Leader [Rif. 55110]
Carlo Catapano
on behalf of
Istituto Oncologico di Ricerca (IOR) USI (Rif. IOR)
is currently Research Program Leader [Rif. 50110] for
Tumor Biology and Experimental Therapeutics (Rif. 10000 2023)
Carlo Catapano
is Head of Research Programs [Rif. 20700]
at Istituto Oncologico di Ricerca (IOR) (Rif. IOR)
Via Francesco Chiesa 5 6500 Bellinzona